Eli Lilly and Company (LLY) は上場企業です ヘルスケア セクターの 製薬 業界で事業展開. 本社所在地は Indianapolis, IN, アメリカ. 現CEOは David A. Ricks.
LLY を有する IPO日 1972-06-01, 47,000 名の正社員, に上場 NYSE, 時価総額 $871.6B.
Eli Lilly and Company is a global pharmaceutical company that discovers, develops, and markets a comprehensive portfolio of human pharmaceuticals across multiple therapeutic areas. The company's offerings span diabetes management with products like Humalog and Humulin insulins, oncology with agents including Alimta, Cyramza, and Verzenio for various cancers, immunology with Olumiant and Taltz for rheumatoid arthritis and psoriatic conditions, and neuroscience with medications such as Cymbalta and Zyprexa. Additionally, Eli Lilly provides treatments for other indications including erectile dysfunction, osteoporosis, and COVID-19, supported by strategic collaborations with leading biotechnology firms. Founded in 1876 and headquartered in Indianapolis, Indiana, the company maintains a strong commitment to innovation and therapeutic advancement across its diverse drug pipeline.
